Torrent Pharmaceuticals dividend and valuation
Valuation
Torrent Pharmaceuticals paid ₹9.00 per share in dividends over the last 12 months (yield 0.2%). Last ex-dividend date: May 29, 2026. The P/E ratio is 79.2. The average price target of 28 analysts is ₹5,472.79.
Data as of November 22, 2026
Torrent Pharmaceuticals compared with similar companies
Torrent Pharmaceuticals's P/E (trailing 12 months): 79.2, +137% against the median of a group of 11 similar companies (33.5).
| Metric | Torrent Pharmaceuticals | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 79.2 | 33.5 | 22.2 – 76.6 | High |
| Forward P/E | 51.6 | 24.9 | 20.1 – 41.9 | High |
| EV/EBITDA | 33.2 | 22.3 | 16.9 – 39.4 | Middle |
| Price/book | 9.70 | 4.20 | 2.33 – 11.9 | Middle |
| Price/sales | 10.3 | 4.17 | 3.56 – 14.2 | Middle |
| Gross margin | 75.9% | 72.2% | 61.5% – 79.2% | Middle |
| Operating margin | 22.2% | 24.1% | 15.1% – 33.9% | Middle |
| Net margin | 12.2% | 17.1% | 12.2% – 33.1% | Middle |
| ROE | 15.7% | 15.7% | 13.9% – 20.7% | Middle |
| Debt/equity | 0.77 | 0.21 | 0.02 – 0.41 | High |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Torrent Pharmaceuticals: valuation over time
On the latest fiscal year's earnings (2026), Torrent Pharmaceuticals's P/E today is 73.4, above the median of its last 10 fiscal years (47.5; between 28.1 and 75.0 from 2017 to 2026). Relative to earnings, the stock costs more than it used to. The dividend yield (0.2%) is below the median of the last 10 fiscal years (1.0%).
| Fiscal year | Price at year end | Earnings per share | P/E | Dividend per share | Yield |
|---|---|---|---|---|---|
| Mar 2026 | ₹4,220.20 | ₹63.92 | 66.0 | ₹38.00 | 0.9% |
| Mar 2025 | ₹3,227.95 | ₹56.47 | 57.2 | ₹32.00 | 1.0% |
| Mar 2024 | ₹2,600.60 | ₹48.94 | 53.1 | ₹28.00 | 1.1% |
| Mar 2023 | ₹1,537.15 | ₹36.79 | 41.8 | ₹22.00 | 1.4% |
| Mar 2022 | ₹1,395.97 | ₹22.96 | 60.8 | ₹16.50 | 1.2% |
| Mar 2021 | ₹1,272.53 | ₹36.99 | 34.4 | ₹17.50 | 1.4% |
| Mar 2020 | ₹985.90 | ₹30.28 | 32.6 | ₹8.50 | 0.9% |
| Mar 2019 | ₹966.72 | ₹12.89 | 75.0 | ₹8.50 | 0.9% |
| Mar 2018 | ₹624.88 | ₹20.04 | 31.2 | ₹7.00 | 1.1% |
| Mar 2017 | ₹776.30 | ₹27.58 | 28.1 | ₹7.00 | 0.9% |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- ₹1.78T
- Enterprise value
- ₹1.89T
- EV/revenue
- 10.9
Profitability and growth
- ROA
- 8.0%
- Revenue growth (year over year)
- 50.8%
- Earnings growth (year over year)
- -19.5%
Financial health
- Total cash
- ₹29.86B
- Total debt
- ₹141.07B
- Current ratio
- 1.32
- Quick ratio
- 0.80
Dividends
- Annual dividend per share
- ₹9.00
- Dividend yield
- 0.2%
- Payout ratio
- 64.2%
- Ex-dividend date
- May 29, 2026
Analysts and estimates
- Average price target
- ₹5,472.79
- Median price target
- ₹5,600.00
- High price target
- ₹6,478.00
- Low price target
- ₹4,545.00
- Analysts with a price target
- 28
- Forward EPS
- ₹90.90
- EPS estimate, current year
- ₹64.06
Shares and trading
- Beta
- 0.17
- Average volume
- 317.7K
- Shares outstanding
- 380.37M
- Float
- 146.73M
- Institutional ownership
- 20.5%
- Insider ownership
- 63.3%
